Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

Author： Hiyoshi H. Yanagimachi M. Ito M. Saeki T. Yoshida I. Okada T. Ikuta H. Shinmyo D. Tanaka K. Kurusu N. Tanaka H.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.431, Iss.3, 2001-11, pp. : 345-352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Major Involvement of Low-Density Lipoprotein Receptor-Related Protein 1 in the Clearance of Plasma Free Amyloid β-Peptide by the Liver

By Tamaki Chihiro Ohtsuki Sumio Iwatsubo Takeshi Hashimoto Tadafumi Yamada Kaoru Yabuki Chiori Terasaki Tetsuya

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1407-1416

Springer Publishing Company

Access to resources Recommend Favorite

Squalene synthase inhibitors 1998

By Rosenberg S.H.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 521-530

Informa Healthcare

Access to resources Recommend Favorite

Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity

Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. : 932-936

Bentham Science Publishers

Access to resources Recommend Favorite

Low density lipoprotein receptor up-regulation

By Chang G. Thompson J.F.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 529-536

Informa Healthcare

Access to resources Recommend Favorite

Acute P-407 Administration to Mice Causes Hypercholesterolemia by Inducing Cholesterolgenesis and Down-Regulating Low-Density Lipoprotein Receptor Expression

By Leon Carlos Wasan Kishor Sachs-Barrable Kristina Johnston Thomas

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1597-1607

Springer Publishing Company

Access to resources Recommend Favorite